Skip to content
PeptideAgent

Telehealth providers in Massachusetts

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in Massachusetts. What Massachusetts requires of telehealth prescribers and pharmacies, plus verified listings.

Massachusetts at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving Massachusetts

No verified telehealth providers serving Massachusetts are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in Massachusetts

Board of Registration in Medicine regulations at 243 CMR 2.01 define the practice of medicine to include telemedicine, and Board Policy 2020-01 (amended in 2022) confirms that a Massachusetts-licensed physician may practice through telemedicine under the same standard of care as an in-person visit, including prescribing when that standard is met. The physician must hold a Massachusetts license to treat a patient located in Massachusetts. Chapter 260 of the Acts of 2020 extended insurance coverage to telehealth, which it defines to include synchronous and asynchronous technology, but no Massachusetts statute expressly authorizes prescribing from a questionnaire alone, so this record leaves asynchronous prescribing unconfirmed. None of the peptides in this database are controlled substances. [2] [3]

Compounded GLP-1 access in Massachusetts

Because compounded GLP-1s are injectable sterile preparations, an out-of-state telehealth program can ship them into Massachusetts only from a pharmacy that holds a Massachusetts nonresident sterile compounding license, which narrows the pool further. [4] [11]

Research use only sellers in Massachusetts

M.G.L. chapter 94 (food and drugs) prohibits selling adulterated or misbranded drugs in Massachusetts, and chapter 112 limits dispensing of prescription drugs to licensed pharmacies and practitioners. [9] [12]

How to check a telehealth provider in Massachusetts

  1. Confirm the prescriber is licensed or registered to treat patients located in Massachusetts; the telehealth rules above explain what Massachusetts requires. [2] [3]
  2. Ask which pharmacy will fill the prescription and check it in the Massachusetts Board of Registration in Pharmacy (Department of Public Health) license lookup. [1] [4] [5] [6] [7] [8] [10]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Massachusetts. [9] [12]

Common questions in Massachusetts

Can an out-of-state pharmacy ship compounded injectable peptides to me in Massachusetts?

Only if the preparation was made in a pharmacy holding a Massachusetts nonresident sterile compounding license, or in an outsourcing facility with a Massachusetts nonresident registration, under M.G.L. chapter 112, section 39J. Check the Board's license lookup before ordering. [1] [4]

All peptide legal questions for Massachusetts

Sources

  1. [1]Massachusetts Board of Registration in Pharmacy
  2. [2]Massachusetts Board of Registration in Medicine: physician regulations (243 CMR 2.00), policies, and guidelines
  3. [3]Massachusetts Board of Registration in Medicine Policy 2020-01, Policy on telemedicine (amended)
  4. [4]M.G.L. chapter 112, section 39J, Non-resident pharmacies; licensure; compounded preparations
  5. [5]M.G.L. chapter 112, section 39G, Retail sterile compounding pharmacies; licensure
  6. [6]Chapter 159 of the Acts of 2014, An Act relative to pharmacy practice in the Commonwealth
  7. [7]247 CMR, Board of Registration in Pharmacy regulations (Trial Court Law Libraries compilation)
  8. [8]Board of Registration in Pharmacy: draft regulations, including draft 247 CMR 17.00 (sterile compounding) and 18.00 (non-sterile compounding)
  9. [9]M.G.L. chapter 94, Inspection and sale of food, drugs and various articles
  10. [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  11. [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  12. [12]21 U.S.C. 331, Prohibited acts